Oral metronomic scheduling of anticancer therapy-based treatment compared to existing standard of care in locally advanced oral squamous cell cancers: a matched-pair
In Indian Journal of Cancer
By: Pai PS.
Contributor(s): Banavali SD | Prabhash K | Vaidya AD | banavali_2000@yahoo.com.
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
Tata Memorial Hospital | Available | AR14118 |
CONTEXT: Head and neck cancers in developing countries present with advanced disease, compounded by poor access to tertiary care centers.
AIM: We evaluated oral metronomic scheduling of anticancer therapy (MSAT) in advanced operable oral cancers, in conjunction with standard therapy.
SETTINGS AND DESIGN: This was a retrospective matched-pair analysis carried out in a tertiary referral cancer center.
MATERIALS AND METHODS: Advanced operable oral cancer patients having a waiting period for surgery > 3 weeks were administered MSAT. Patients then underwent standard therapy (surgery +/- adjuvant radiation/chemoradiation) as warranted by the disease, followed by MSAT maintenance therapy. Outcomes of the MSAT group were compared with stage-matched controls with similar waiting periods.
STATISTICAL ANALYSIS: Survivals were found using the Kaplan-Meier method and compared between groups using the log rank test.
RESULTS: Response was seen in 75% of 32 patients. Two-year disease-free survivals (DFS) in
There are no comments for this item.